ASCVD Management Using CCTA in Prostate Cancer Patients on ADT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT — Stella

Home/Prostate Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Prostate Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

United States

IU Health Joe and Shelly Schwarz Cancer Center, Carmel, Indiana

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana

Methodist Hospital, Indianapolis, Indiana

Key details

Sponsor

Indiana University

Collaborators

National Comprehensive Cancer Network, Pfizer

Enrollment target

~100 participants

Started

December 2023

Primary completion

December 2026

Age range

40 Years and older

Sex

Male only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.